Position in MRK
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$4,938,126
+$1,331,592 QoQ
Shares Held
38,429
+28.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,050
of 3,769 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CWA Asset Management Group, LLC holds $104,319,210 across 14 Drug Manufacturers - General names. MRK ranks #7 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
97,695 | $24,811,599 | |
| 2 | ABBV |
AbbVie Inc.
|
86,259 | $21,706,214 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
179,351 | $10,334,204 | |
| 4 | LLY |
ELI LILLY & Co
|
7,425 | $8,905,768 | |
| 5 | BIIB |
Biogen Inc.
|
38,127 | $8,237,719 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
63,399 | $8,009,829 | |
| 7 | MRK |
Merck & Co., Inc.
This page
|
38,429 | $4,938,126 | |
| 8 | NVS |
Novartis AG
|
29,083 | $4,557,887 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,938,126 | 38,429 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $3,606,534 | 29,982 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $5,851,613 | 55,592 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $2,505,814 | 29,856 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,931,928 | 37,038 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,538,698 | 39,424 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $2,621,198 | 26,349 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $4,279,054 | 37,681 | Shares | Sole | 2024-11-01 | |
| 2024-03-31 | $2,169,126 | 16,439 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,653,179 | 15,164 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,271,329 | 12,349 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,549,226 | 13,426 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $1,355,621 | 12,742 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $1,452,668 | 13,093 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $1,360,265 | 15,795 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,324,517 | 14,528 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,070,096 | 13,042 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $684,471 | 8,931 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $767,248 | 10,215 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,466,964 | 83,155 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $5,399,155 | 70,037 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $11,803,734 | 144,300 | Shares | Sole | 2021-02-23 | |
| 2020-09-30 | $10,674,176 | 128,682 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,052,685 | 104,134 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,343,908 | 108,447 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||